Company Filing History:
Years Active: 2015
Title: Innovations by Marina Safonov
Introduction
Marina Safonov is an accomplished inventor based in Escondido, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments related to sphingosine-1-phosphate (S1P). With two patents to her name, her work focuses on innovative compositions and methods for treating various ocular diseases.
Latest Patents
Marina's latest patents include "Pharmaceutical compositions for binding sphingosine-1-phosphate" and "Anti-S1P antibody treatment of patients with ocular disease." The first patent relates to compositions that comprise an anti-S1P monoclonal antibody, antibody fragment, or derivative in a carrier, particularly a buffered, hypertonic aqueous solution. This invention also includes kits containing such compositions and methods for using them to treat diseases associated with S1P. The second patent outlines methods for administering an anti-S1P antibody or its derivatives to subjects with ocular diseases, including those involving choroidal neovascularization. This treatment aims to reduce the size of lesions in the eye and improve visual acuity, particularly for patients with age-related macular degeneration.
Career Highlights
Marina Safonov is currently associated with Lpath, Inc., where she continues to innovate in the pharmaceutical sector. Her work has the potential to significantly impact the treatment of ocular diseases, showcasing her dedication to advancing medical science.
Collaborations
Marina has collaborated with notable colleagues, including Scott R Pancoast and Glenn L Stoller, contributing to a dynamic research environment that fosters innovation.
Conclusion
Marina Safonov's contributions to the field of pharmaceuticals, particularly in ocular treatments, highlight her role as a leading inventor. Her patents reflect a commitment to improving patient outcomes through innovative solutions.